Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Connie Hess

Concepts (261)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
48
2024
486
11.730
 Why?
Percutaneous Coronary Intervention
22
2021
486
4.420
 Why?
Coronary Artery Disease
17
2024
701
4.340
 Why?
Lower Extremity
24
2024
438
4.220
 Why?
Myocardial Infarction
18
2023
1069
3.780
 Why?
Platelet Aggregation Inhibitors
28
2025
470
3.540
 Why?
Fibrinolytic Agents
13
2025
278
3.410
 Why?
Endovascular Procedures
8
2024
347
2.730
 Why?
Radial Artery
9
2019
69
2.580
 Why?
Purinergic P2Y Receptor Antagonists
8
2018
66
2.330
 Why?
Acute Coronary Syndrome
7
2023
281
2.180
 Why?
Rivaroxaban
15
2024
256
2.090
 Why?
Vascular Surgical Procedures
7
2024
318
2.040
 Why?
Aspirin
15
2024
391
2.020
 Why?
Ischemia
9
2023
416
1.690
 Why?
Femoral Artery
9
2024
183
1.670
 Why?
Stroke
10
2022
1138
1.500
 Why?
Hemorrhage
17
2025
732
1.410
 Why?
Anticoagulants
10
2024
669
1.390
 Why?
Treatment Outcome
42
2024
10961
1.380
 Why?
Drug-Eluting Stents
4
2021
84
1.330
 Why?
Anticholesteremic Agents
3
2023
151
1.270
 Why?
Postoperative Complications
6
2021
2738
1.230
 Why?
Atherosclerosis
6
2024
400
1.220
 Why?
Hypercholesterolemia
2
2022
104
1.220
 Why?
Cholesterol, LDL
5
2024
359
1.200
 Why?
Patient Readmission
4
2021
706
1.160
 Why?
Venous Thromboembolism
2
2023
324
1.140
 Why?
Atrial Fibrillation
4
2017
377
1.020
 Why?
Factor Xa Inhibitors
7
2024
172
1.020
 Why?
Cardiovascular Diseases
7
2024
2057
1.020
 Why?
Aged
44
2024
24236
0.990
 Why?
Disease Management
4
2021
620
0.980
 Why?
Ticlopidine
3
2016
52
0.960
 Why?
Humans
100
2025
139062
0.960
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2024
449
0.910
 Why?
Saphenous Vein
2
2015
36
0.900
 Why?
Graft Occlusion, Vascular
2
2015
39
0.890
 Why?
Learning Curve
2
2015
69
0.850
 Why?
Cardiac Catheterization
3
2018
527
0.850
 Why?
Thrombosis
4
2024
383
0.820
 Why?
Female
56
2024
74074
0.810
 Why?
Middle Aged
40
2024
33864
0.810
 Why?
Risk Factors
26
2024
10426
0.800
 Why?
Coronary Artery Bypass
2
2015
237
0.800
 Why?
Warfarin
2
2015
155
0.790
 Why?
Pyridones
2
2015
170
0.780
 Why?
Fibrin Fibrinogen Degradation Products
1
2023
91
0.780
 Why?
Male
50
2024
68324
0.780
 Why?
Antifibrinolytic Agents
1
2023
49
0.780
 Why?
Coronary Vessels
4
2024
246
0.760
 Why?
Sex Characteristics
3
2023
769
0.750
 Why?
Postoperative Hemorrhage
2
2013
88
0.750
 Why?
Brain Ischemia
2
2022
343
0.730
 Why?
Blood Coagulation Disorders
1
2023
178
0.700
 Why?
Paclitaxel
2
2021
237
0.700
 Why?
Diabetes Complications
2
2021
226
0.700
 Why?
Gout
2
2018
38
0.690
 Why?
Pyrazoles
2
2015
429
0.690
 Why?
Heparin
3
2023
262
0.690
 Why?
Hypolipidemic Agents
1
2021
90
0.680
 Why?
Angina Pectoris
2
2017
64
0.650
 Why?
Registries
12
2024
2054
0.640
 Why?
Dyslipidemias
1
2021
169
0.620
 Why?
Leg
1
2021
233
0.620
 Why?
Patient Care Team
1
2024
642
0.600
 Why?
Drug Therapy, Combination
11
2024
1049
0.580
 Why?
Myocardial Revascularization
2
2016
74
0.580
 Why?
Reperfusion
1
2018
44
0.580
 Why?
Coronary Angiography
4
2024
321
0.570
 Why?
Risk Assessment
11
2021
3469
0.570
 Why?
Upper Extremity
1
2018
105
0.530
 Why?
Consensus
2
2017
679
0.530
 Why?
Time Factors
13
2021
6885
0.520
 Why?
American Heart Association
5
2024
284
0.520
 Why?
Databases, Factual
2
2021
1404
0.500
 Why?
Societies, Medical
3
2024
839
0.470
 Why?
Medicare
4
2021
790
0.460
 Why?
Quality Indicators, Health Care
3
2023
307
0.450
 Why?
Acute Disease
4
2021
1011
0.450
 Why?
Popliteal Artery
4
2024
62
0.440
 Why?
Coronary Disease
1
2017
374
0.430
 Why?
Intermittent Claudication
3
2024
122
0.430
 Why?
Cardiology
4
2024
277
0.430
 Why?
Coronary Vessel Anomalies
2
2024
36
0.420
 Why?
United States
23
2024
15065
0.420
 Why?
Recurrence
5
2020
1103
0.420
 Why?
Hospitals
3
2017
696
0.410
 Why?
Follow-Up Studies
6
2021
5165
0.410
 Why?
Office Visits
1
2013
95
0.400
 Why?
Sex Factors
7
2024
2054
0.370
 Why?
Hematoma
2
2022
54
0.370
 Why?
Aftercare
1
2013
213
0.360
 Why?
Vascular Diseases
2
2024
242
0.350
 Why?
Subclavian Vein
1
2011
15
0.350
 Why?
Subclavian Artery
1
2011
28
0.350
 Why?
Arteriovenous Fistula
1
2011
36
0.340
 Why?
Comorbidity
5
2024
1656
0.340
 Why?
Thrombocytopenia
1
2012
205
0.340
 Why?
Health Status Disparities
1
2014
299
0.330
 Why?
Electric Countershock
1
2011
101
0.330
 Why?
Catheterization
1
2011
181
0.330
 Why?
Referral and Consultation
1
2016
799
0.320
 Why?
Quality of Life
3
2022
2954
0.320
 Why?
Randomized Controlled Trials as Topic
2
2024
1516
0.310
 Why?
Adenosine Diphosphate
1
2009
82
0.310
 Why?
Proportional Hazards Models
4
2021
1286
0.300
 Why?
Nitric Oxide Synthase Type III
1
2009
203
0.290
 Why?
Cardiovascular Agents
2
2022
155
0.290
 Why?
Gene Expression Regulation, Enzymologic
1
2009
277
0.290
 Why?
Prospective Studies
8
2024
7660
0.280
 Why?
Retrospective Studies
9
2024
15922
0.280
 Why?
AMP-Activated Protein Kinases
1
2009
201
0.280
 Why?
Defibrillators, Implantable
1
2011
304
0.280
 Why?
Peptides
1
2013
984
0.270
 Why?
Vascular System Injuries
2
2019
75
0.270
 Why?
Cardiomyopathies
1
2011
324
0.270
 Why?
Healthcare Disparities
1
2014
661
0.260
 Why?
Catheterization, Peripheral
2
2019
108
0.260
 Why?
Cause of Death
3
2018
426
0.250
 Why?
Double-Blind Method
4
2020
1946
0.250
 Why?
Aged, 80 and over
7
2021
7698
0.230
 Why?
Ankle Brachial Index
2
2022
37
0.230
 Why?
Kaplan-Meier Estimate
3
2021
903
0.210
 Why?
Endothelial Cells
1
2009
794
0.210
 Why?
Patient Discharge
3
2021
909
0.210
 Why?
Neoplasms
2
2017
2703
0.210
 Why?
Arteries
2
2022
263
0.210
 Why?
Age Factors
4
2016
3273
0.210
 Why?
Secondary Prevention
2
2025
237
0.200
 Why?
Thromboplastin
1
2023
73
0.200
 Why?
Migraine Disorders
1
2024
105
0.190
 Why?
Incidence
5
2021
2836
0.190
 Why?
Longitudinal Studies
5
2018
2846
0.190
 Why?
Myocardial Ischemia
2
2015
278
0.190
 Why?
Numbers Needed To Treat
1
2021
7
0.180
 Why?
Ulcer
1
2021
34
0.180
 Why?
Lactones
1
2022
58
0.180
 Why?
Odds Ratio
2
2022
1084
0.180
 Why?
Walking
2
2022
535
0.170
 Why?
Syndrome
1
2021
379
0.170
 Why?
Angioplasty, Balloon
1
2021
93
0.170
 Why?
Clinical Trials as Topic
2
2017
1036
0.170
 Why?
Cholesterol
1
2022
401
0.170
 Why?
Limb Salvage
1
2020
65
0.170
 Why?
Antineoplastic Agents, Phytogenic
1
2021
191
0.160
 Why?
Pharmaceutical Preparations
1
2021
179
0.150
 Why?
Patient Education as Topic
1
2024
763
0.150
 Why?
United Kingdom
1
2020
321
0.150
 Why?
Hypertension
2
2022
1251
0.150
 Why?
Extremities
1
2020
137
0.150
 Why?
Aorta
1
2021
415
0.150
 Why?
Receptors, Purinergic P2Y12
1
2018
6
0.150
 Why?
Hospitalization
2
2019
2223
0.150
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2018
23
0.150
 Why?
Pyridines
1
2022
498
0.140
 Why?
Antithrombins
1
2018
62
0.140
 Why?
Cohort Studies
2
2022
5736
0.140
 Why?
Non-ST Elevated Myocardial Infarction
1
2017
23
0.140
 Why?
Stents
3
2020
529
0.140
 Why?
Exercise Therapy
1
2022
440
0.130
 Why?
Practice Guidelines as Topic
2
2017
1550
0.130
 Why?
ST Elevation Myocardial Infarction
1
2017
55
0.130
 Why?
Plaque, Atherosclerotic
1
2017
58
0.130
 Why?
Diabetes Mellitus, Type 2
2
2024
2514
0.120
 Why?
Intraoperative Complications
1
2017
148
0.120
 Why?
Mortality
1
2018
360
0.120
 Why?
Stress Disorders, Post-Traumatic
1
2024
848
0.120
 Why?
Uric Acid
1
2017
165
0.120
 Why?
North Carolina
1
2015
117
0.120
 Why?
Antibodies, Monoclonal
2
2023
1439
0.110
 Why?
Hospital Bed Capacity
1
2014
27
0.110
 Why?
Blood Platelets
1
2018
426
0.110
 Why?
Hospitals, Low-Volume
1
2014
23
0.110
 Why?
Hospitals, High-Volume
1
2014
44
0.110
 Why?
Clinical Trials Data Monitoring Committees
1
2014
3
0.110
 Why?
Vascular Patency
1
2014
111
0.110
 Why?
Smoking
1
2022
1607
0.110
 Why?
Diagnosis-Related Groups
1
2013
31
0.100
 Why?
Prosthesis Design
2
2017
332
0.100
 Why?
Professional Competence
1
2014
98
0.100
 Why?
Diabetes Mellitus
1
2022
1055
0.100
 Why?
Logistic Models
1
2018
2089
0.100
 Why?
Survivors
1
2017
500
0.100
 Why?
Fee-for-Service Plans
1
2013
87
0.100
 Why?
Guideline Adherence
1
2017
557
0.100
 Why?
Platelet Factor 4
1
2012
35
0.100
 Why?
Practice Patterns, Physicians'
2
2018
1315
0.100
 Why?
Infusions, Intravenous
1
2013
415
0.090
 Why?
Inflammation
1
2023
2858
0.090
 Why?
Antibodies, Monoclonal, Humanized
1
2017
816
0.090
 Why?
Heart Failure
2
2016
2059
0.090
 Why?
Prognosis
2
2021
4024
0.080
 Why?
Prevalence
3
2024
2746
0.080
 Why?
Radiography, Interventional
1
2011
123
0.080
 Why?
Reoperation
2
2024
587
0.080
 Why?
Naphthalimides
1
2009
2
0.080
 Why?
Calcium-Calmodulin-Dependent Protein Kinase Kinase
1
2009
4
0.080
 Why?
Heart Diseases
1
2013
336
0.080
 Why?
Hospital Mortality
1
2014
919
0.080
 Why?
Predictive Value of Tests
1
2014
2044
0.070
 Why?
Sensitivity and Specificity
1
2013
1958
0.070
 Why?
Benzimidazoles
1
2009
177
0.070
 Why?
Protein Isoforms
1
2009
396
0.070
 Why?
Communication
1
2014
932
0.070
 Why?
Enzyme Activation
1
2009
819
0.070
 Why?
Combined Modality Therapy
2
2021
1237
0.070
 Why?
Case-Control Studies
1
2015
3584
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
369
0.070
 Why?
Cattle
1
2009
997
0.060
 Why?
Clinical Competence
1
2014
1140
0.060
 Why?
Quality Improvement
1
2014
1202
0.060
 Why?
Phosphorylation
1
2009
1770
0.060
 Why?
Autoantibodies
1
2012
1454
0.060
 Why?
Cell Movement
1
2009
972
0.060
 Why?
Young Adult
1
2021
13341
0.060
 Why?
Fibromuscular Dysplasia
1
2024
8
0.050
 Why?
Atherectomy
1
2024
37
0.050
 Why?
Subtilisin
1
2023
4
0.050
 Why?
Proprotein Convertases
1
2023
16
0.050
 Why?
Angiography
1
2024
210
0.050
 Why?
Lipoprotein(a)
1
2023
66
0.050
 Why?
Proprotein Convertase 9
1
2023
74
0.050
 Why?
Disability Evaluation
1
2024
298
0.050
 Why?
Adult
2
2024
38389
0.050
 Why?
Adolescent
1
2021
21561
0.050
 Why?
Mobility Limitation
1
2022
60
0.050
 Why?
Coated Materials, Biocompatible
1
2021
65
0.040
 Why?
Public Health Surveillance
1
2021
84
0.040
 Why?
Diagnostic Tests, Routine
1
2021
112
0.040
 Why?
Smoking Cessation
1
2024
434
0.040
 Why?
Internationality
1
2020
158
0.040
 Why?
Disease Susceptibility
1
2021
350
0.040
 Why?
Punctures
1
2019
39
0.040
 Why?
Advisory Committees
1
2021
220
0.040
 Why?
Chronic Disease
1
2025
1802
0.040
 Why?
Global Health
1
2021
387
0.030
 Why?
Drug Utilization Review
1
2017
58
0.030
 Why?
Health Care Costs
1
2021
418
0.030
 Why?
Surgery, Computer-Assisted
1
2017
75
0.030
 Why?
Dose-Response Relationship, Drug
1
2021
2051
0.030
 Why?
Socioeconomic Factors
1
2021
1310
0.030
 Why?
Comparative Effectiveness Research
1
2017
156
0.030
 Why?
Chi-Square Distribution
1
2017
525
0.030
 Why?
Signal Transduction
1
2009
5094
0.030
 Why?
Genetic Predisposition to Disease
1
2024
2369
0.030
 Why?
Drug Prescriptions
1
2017
259
0.030
 Why?
Platelet Function Tests
1
2015
28
0.030
 Why?
Patient Selection
1
2019
692
0.030
 Why?
Administration, Oral
1
2017
790
0.030
 Why?
Hypoglycemic Agents
1
2024
1307
0.030
 Why?
Early Termination of Clinical Trials
1
2014
18
0.030
 Why?
Depression
1
2024
1467
0.030
 Why?
Multivariate Analysis
1
2017
1498
0.030
 Why?
Retreatment
1
2013
73
0.030
 Why?
Canada
1
2014
412
0.020
 Why?
Mass Screening
1
2021
1287
0.020
 Why?
Patient Preference
1
2014
197
0.020
 Why?
Linear Models
1
2014
856
0.020
 Why?
Pregnancy
1
2023
6874
0.020
 Why?
Animals
1
2009
37351
0.020
 Why?
Hess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (261) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)